Lori Macomber's most recent trade in Karyopharm Therapeutics Inc was a trade of 650,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc | Lori Macomber | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 650,000 | 650,000 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Lori Macomber | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 160,000 | 160,000 (0%) | 0% | 0 | Common Stock |